Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6-17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial.
Thomas P A DanneWilliam V TamborlaneOleg A MalievskyDenise R FrancoTomoyuki KawamuraMarek DemissieElisabeth NiemoellerHarmonie GoyeauMarek WardeckiTadej BattelinoPublished in: Diabetes care (2020)
Gla-300 provided similar glycemic control and safety profiles to Gla-100 in children and adolescents with type 1 diabetes, indicating that Gla-300 is a suitable therapeutic option in this population.